Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID DTD0014 Transporter Info
Gene Name ABCB11
Transporter Name Bile salt export pump
Gene ID
8647
UniProt ID
O95342
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Approved Drug

  Cyclosporine

            9 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cyclosporine inhibits the transportation of Glycocholate by ABCB11 (IC50 = 0.93 microM) [1]

Affected Drug/Substrate

 Glycocholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  DT Modulation 2

 Cyclosporine inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 18.9 microM) [1]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  DT Modulation 3

 Cyclosporine inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 8.4 microM) [1]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  DT Modulation 4

 Cyclosporine inhibits the transportation of Taurochenodeoxycholate by ABCB11 (IC50 = 0.94 microM) [1]

Affected Drug/Substrate

 Taurochenodeoxycholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  DT Modulation 5

 Cyclosporine inhibits the transportation of Taurochenodeoxycholate by ABCB11 (Ki = 9.5 microM) [2]

Affected Drug/Substrate

 Taurochenodeoxycholate Modulation Type Inhibition

Cell System

 High Five cells-BSEP

  DT Modulation 6

 Cyclosporine inhibits the transportation of Bodipy by ABCB11 (IC50 = 7.5 microM) [3]

Affected Drug/Substrate

 Bodipy Modulation Type Inhibition

  DT Modulation 7

 Cyclosporine inhibits the transportation of Dihydrofluorescein by ABCB11 (IC50 = 7.8 microM) [3]

Affected Drug/Substrate

 Dihydrofluorescein Modulation Type Inhibition

  DT Modulation 8

 Cyclosporine inhibits the transportation of Sodium taurocholate by ABCB11 [4]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Hepatocyte-BSEP

  DT Modulation 9

 Cyclosporine inhibits the activity of ABCB11 [5]

  Glyburide

            8 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glibenclamide inhibits the transportation of Glycocholate by ABCB11 (IC50 = 18.8 microM) [1]

Affected Drug/Substrate

 Glycocholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  DT Modulation 2

 Glibenclamide inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 14.7 microM) [1]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  DT Modulation 3

 Glibenclamide inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 11.3 microM) [1]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  DT Modulation 4

 Glibenclamide inhibits the transportation of Sodium taurocholate by ABCB11 (Ki = 27.5 microM) [2]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 High Five cells-BSEP

  DT Modulation 5

 Glibenclamide inhibits the transportation of Taurochenodeoxycholate by ABCB11 (IC50 = 15.8 microM) [1]

Affected Drug/Substrate

 Taurochenodeoxycholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  DT Modulation 6

 Glibenclamide inhibits the transportation of Bodipy by ABCB11 (IC50 = 260.1 microM) [3]

Affected Drug/Substrate

 Bodipy Modulation Type Inhibition

  DT Modulation 7

 Glibenclamide inhibits the transportation of Dihydrofluorescein by ABCB11 (IC50 = 146.5 microM) [3]

Affected Drug/Substrate

 Dihydrofluorescein Modulation Type Inhibition

  DT Modulation 8

 Glibenclamide inhibits the activity of ABCB11 [6] , [7]

  Troglitazone

            4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Troglitazone inhibits the transportation of Glycocholate by ABCB11 (IC50 = 16 microM) [1]

Affected Drug/Substrate

 Glycocholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  DT Modulation 2

 Troglitazone inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 9.5 microM) [1]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  DT Modulation 3

 Troglitazone inhibits the transportation of Taurochenodeoxycholate by ABCB11 (IC50 = 27.6 microM) [1]

Affected Drug/Substrate

 Taurochenodeoxycholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  DT Modulation 4

 Troglitazone induces the activity of ABCB11 [8]

  Progesterone

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Progesterone inhibits the transportation of Bodipy by ABCB11 (IC50 = 224.6 microM) [3]

Affected Drug/Substrate

 Bodipy Modulation Type Inhibition

  DT Modulation 2

 Progesterone inhibits the transportation of Dihydrofluorescein by ABCB11 (IC50 = 17.3 microM) [3]

Affected Drug/Substrate

 Dihydrofluorescein Modulation Type Inhibition

  Atorvastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Atorvastatin inhibits the transportation of Sodium taurocholate by ABCB11 (Ki = 9.12 microM) [9]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-BSEP

  Cerivastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cerivastatin inhibits the transportation of Sodium taurocholate by ABCB11 (Ki = 11.4 microM) [9]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-BSEP

  Clofazimine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Clofazimine inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 2.3 microM) [1]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  Reserpine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Reserpine inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 2.8 microM) [1]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  Rifampicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rifampicin inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 10.5 microM) [1]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  Candesartan cilexetil

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Candesartan cilexetil inhibits the activity of ABCB11 (IC50 = 6.2 microM) [11]

Cell System

 Human hepatocytes-BSEP

  Chenodeoxycholic acid

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chenodiol induces the activity of ABCB11 [12]

Cell System

 Hepatocyte-BSEP

  DT Modulation 2

 Chenodeoxycholic acid induces the activity of ABCB11 [36] , [37]

  Rifampin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rifampin inhibits the expression of ABCB11 [14]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 Human hepatocytes (HH1089)

  Ursodeoxycholic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ursodeoxycholic Acid increases the expression of ABCB11 [15]

Regulation Mechanism

 via enhancement of Bile acid receptor (NR1H4) Transcription Factor Info

Cell System

 C57/BL6 mice

  Deoxycholic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Deoxycholic acid increases the expression of ABCB11 [16]

Regulation Mechanism

 via enhancement of Bile acid receptor (NR1H4) Transcription Factor Info

Cell System

 New zealand white rabbits

  Obeticholic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Obeticholic acid increases the expression of ABCB11 [17]

Regulation Mechanism

 via enhancement of Bile acid receptor (NR1H4) Transcription Factor Info

Cell System

 C57BL6/J mice

  Tamoxifen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tamoxifen inhibits the activity of ABCB11 [3]

  Phenobarbital

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Phenobarbital inhibits the expression of ABCB11 [19]

  Methimazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Methimazole increases the expression of ABCB11 [20]

  Amprenavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Amprenavir inhibits the activity of ABCB11 [21]

  Clofibrate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Clofibrate inhibits the activity of ABCB11 [21]

  Dicloxacillin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dicloxacillin inhibits the activity of ABCB11 [21]

  Finasteride

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Finasteride inhibits the activity of ABCB11 [21]

  Mibefradil

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Mibefradil inhibits the activity of ABCB11 [21]

  Omeprazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Omeprazole inhibits the activity of ABCB11 [21]

  Primaquine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Primaquine inhibits the activity of ABCB11 [21]

  Sorafenib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sorafenib inhibits the activity of ABCB11 [21]

  Tolcapone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tolcapone inhibits the activity of ABCB11 [21]

  Dexamethasone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dexamethasone increases the expression of ABCB11 [22]

  Acetaminophen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acetaminophen inhibits the expression of ABCB11 [23]

  Bromfenac

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bromfenac inhibits the activity of ABCB11 [24]

  Clozapine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Clozapine inhibits the activity of ABCB11 [24]

  Olanzapine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Olanzapine inhibits the activity of ABCB11 [24]

  Ticlopidine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ticlopidine inhibits the activity of ABCB11 [24]

  Cisapride

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cisapride inhibits the activity of ABCB11 [25]

  Danazol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Danazol inhibits the activity of ABCB11 [25]

  Dasatinib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dasatinib inhibits the activity of ABCB11 [25]

  Drospirenone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Drospirenone inhibits the activity of ABCB11 [25]

  Everolimus

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Everolimus inhibits the activity of ABCB11 [25]

  Iloperidone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Iloperidone inhibits the activity of ABCB11 [25]

  Irbesartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Irbesartan inhibits the activity of ABCB11 [25]

  Medroxyprogesterone Acetate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Medroxyprogesterone Acetate inhibits the activity of ABCB11 [25]

  Megestrol Acetate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Megestrol Acetate inhibits the activity of ABCB11 [25]

  Neratinib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Neratinib inhibits the activity of ABCB11 [25]

  Olmesartan medoxomil

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Olmesartan medoxomil inhibits the activity of ABCB11 [25]

  pimecrolimus

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 pimecrolimus inhibits the activity of ABCB11 [25]

  Posaconazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Posaconazole inhibits the activity of ABCB11 [25]

  Rifapentine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rifapentine inhibits the activity of ABCB11 [25]

  Tacrolimus

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tacrolimus inhibits the activity of ABCB11 [25]

  Temsirolimus

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Temsirolimus inhibits the activity of ABCB11 [25]

  Atropine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Atropine inhibits the activity of ABCB11 [26]

  Cefaclor

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefaclor inhibits the activity of ABCB11 [26]

  Cholic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cholic Acid inhibits the activity of ABCB11 [26]

  Clarithromycin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Clarithromycin inhibits the activity of ABCB11 [26]

  Clotrimazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Clotrimazole inhibits the activity of ABCB11 [26]

  Diethylstilbestrol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Diethylstilbestrol inhibits the activity of ABCB11 [26]

  Efavirenz

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Efavirenz inhibits the activity of ABCB11 [26]

  Erythromycin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Erythromycin inhibits the activity of ABCB11 [26]

  Ezetimibe

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ezetimibe inhibits the activity of ABCB11 [26]

  Felodipine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Felodipine inhibits the activity of ABCB11 [26]

  Fluvoxamine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fluvoxamine inhibits the activity of ABCB11 [26]

  Glipizide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glipizide inhibits the activity of ABCB11 [26]

  Indocyanine green

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Indocyanine green inhibits the activity of ABCB11 [26]

  Isradipine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Isradipine inhibits the activity of ABCB11 [26]

  Naproxen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Naproxen inhibits the activity of ABCB11 [26]

  Nifedipine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Nifedipine inhibits the activity of ABCB11 [26]

  Nitrofurantoin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Nitrofurantoin inhibits the activity of ABCB11 [26]

  Ofloxacin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ofloxacin inhibits the activity of ABCB11 [26]

  Pitavastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pitavastatin inhibits the activity of ABCB11 [26]

  Ranolazine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ranolazine inhibits the activity of ABCB11 [26]

  Spironolactone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Spironolactone inhibits the activity of ABCB11 [26]

  Sulfinpyrazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulfinpyrazone inhibits the activity of ABCB11 [26]

  Tinidazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tinidazole inhibits the activity of ABCB11 [26]

  Vinblastine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Vinblastine inhibits the activity of ABCB11 [26]

  Tolvaptan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tolvaptan inhibits the activity of ABCB11 [27]

  Ethinyl Estradiol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ethinyl Estradiol inhibits the expression of ABCB11 [28]

  Bicalutamide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bicalutamide inhibits the activity of ABCB11 [29]

  Dihydroergotamine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dihydroergotamine inhibits the activity of ABCB11 [29]

  Liothyronine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Liothyronine inhibits the activity of ABCB11 [29]

  Primidone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Primidone inhibits the activity of ABCB11 [29]

  Valproic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valproic Acid inhibits the expression of ABCB11 [30]

  Tretinoin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tretinoin increases the expression of ABCB11 [31]

  Menadione

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Menadione inhibits the expression of ABCB11 [32]

  Nefazodone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Nefazodone inhibits the activity of ABCB11 [29]

  Pioglitazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pioglitazone inhibits the activity of ABCB11 [25]

  Rosiglitazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rosiglitazone inhibits the activity of ABCB11 [26]

  Ritonavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ritonavir inhibits the activity of ABCB11 [29]

  Indomethacin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Indomethacin inhibits the activity of ABCB11 [26]

  Gefitinib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gefitinib inhibits the activity of ABCB11 [25]

  Paclitaxel

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Paclitaxel inhibits the activity of ABCB11 [25]

  Fenofibrate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fenofibrate inhibits the activity of ABCB11 [26]

  Glimepiride

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glimepiride inhibits the activity of ABCB11 [26]

  Lopinavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lopinavir inhibits the activity of ABCB11 [26]

  Nelfinavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Nelfinavir inhibits the activity of ABCB11 [26]

  Nicardipine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Nicardipine inhibits the activity of ABCB11 [26]

  Saquinavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Saquinavir inhibits the activity of ABCB11 [26]

  Simvastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Simvastatin inhibits the activity of ABCB11 [26]

  Telmisartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Telmisartan inhibits the activity of ABCB11 [26]

  Indinavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Indinavir inhibits the activity of ABCB11 [29]

  Lapatinib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lapatinib inhibits the activity of ABCB11 [29]

  Pazopanib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pazopanib inhibits the activity of ABCB11 [29]

  Amiodarone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Amiodarone inhibits the activity of ABCB11 [26]

  Imatinib Mesylate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Imatinib Mesylate inhibits the activity of ABCB11 [26]

  Midazolam

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Midazolam inhibits the activity of ABCB11 [26]

  Celecoxib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Celecoxib inhibits the activity of ABCB11 [26]

  Dipyridamole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dipyridamole inhibits the activity of ABCB11 [26]

  Losartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Losartan inhibits the activity of ABCB11 [26]

  Lovastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lovastatin inhibits the activity of ABCB11 [26]

  Mifepristone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Mifepristone inhibits the activity of ABCB11 [26]

  Repaglinide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Repaglinide inhibits the activity of ABCB11 [26]

  Loratadine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Loratadine inhibits the activity of ABCB11 [29]

  Zafirlukast

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Zafirlukast inhibits the activity of ABCB11 [29]

  Diclofenac

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Diclofenac inhibits the activity of ABCB11 [29]

  Tipranavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tipranavir inhibits the activity of ABCB11 [29]

  Atenolol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Atenolol inhibits the activity of ABCB11 [26]

  Budesonide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Budesonide inhibits the activity of ABCB11 [26]

  Disulfiram

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Disulfiram inhibits the activity of ABCB11 [26]

  Conjugated estrogens

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Conjugated estrogens inhibits the activity of ABCB11 [33]

  Fluvastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fluvastatin inhibits the activity of ABCB11 [33]

  Pravastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pravastatin inhibits the activity of ABCB11 [34]

  Bosentan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bosentan inhibits the activity of ABCB11 [35]

  Cloxacillin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cloxacillin inhibits the activity of ABCB11 [38]

  Midecamycin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Midecamycin inhibits the activity of ABCB11 [38]

  Colchicine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Colchicine induces the activity of ABCB11 [39]

  Rifamycin SV

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rifamycin SV inhibits the activity of ABCB11 [40]

  Micafungin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Micafungin inhibits the activity of ABCB11 [41]

  Itraconazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Itraconazole inhibits the activity of ABCB11 [42]

  Ketoconazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ketoconazole inhibits the activity of ABCB11 [42]

Drug Marketed but not Approved by US FDA

  Bezafibrate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bezafibrate inhibits the expression of ABCB11 [18]

  Etoricoxib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Etoricoxib inhibits the activity of ABCB11 [21]

  Gliquidone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gliquidone inhibits the activity of ABCB11 [25]

  Pranlukast

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pranlukast inhibits the activity of ABCB11 [25]

  Floxacillin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Floxacillin inhibits the activity of ABCB11 [26]

  Benzbromarone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzbromarone inhibits the activity of ABCB11 [29]

  Nitrendipine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Nitrendipine inhibits the activity of ABCB11 [26]

Drug in Phase 3 Trial

  Oltipraz

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Oltipraz increases the expression of ABCB11 [44]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Epigallocatechin gallate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Epigallocatechin gallate increases the expression of ABCB11 [47]

  Glycyrrhizic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glycyrrhizic Acid inhibits the activity of ABCB11 [26]

  Diethyltoluamide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Diethyltoluamide inhibits the expression of ABCB11 [50]

  Vitamin E

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Vitamin E inhibits the expression of ABCB11 [32]

  Fusidic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fusidic Acid inhibits the activity of ABCB11 [26]

Drug in Phase 2 Trial

  Ethanol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ethanol inhibits the expression of ABCB11 [59]

Drug in Phase 1 Trial

  Astemizole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Astemizole inhibits the activity of ABCB11 [26]

  Prasterone sulfate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Prasterone sulfate inhibits the activity of ABCB11 [26]

  TAK-875

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 TAK-875 inhibits the activity of ABCB11 [53]

  ANA-756

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 ANA-756 inhibits the activity of ABCB11 [29]

  Sodium arsenite

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sodium arsenite inhibits the expression of ABCB11 [55]

  Quercetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Quercetin inhibits the expression of ABCB11 [32]

  Cinnarizine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cinnarizine inhibits the activity of ABCB11 [25]

Drug in Preclinical Test

  AM-2282

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 AM-2282 inhibits the activity of ABCB11 [25]

Investigative Drug

  Valinomycin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valinomycin inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 0.7 microM) [1]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-BSEP

  Epigalocatechin gallate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Epigalocatechin gallate inhibits the transportation of Bodipy by ABCB11 (IC50 = 214 microM) [3]

Affected Drug/Substrate

 Bodipy Modulation Type Inhibition

  Lithocholic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lithocholic Acid inhibits the expression of ABCB11 [43]

Regulation Mechanism

 via the inhibition of Bile acid receptor (NR1H4) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Ciglitazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ciglitazone inhibits the activity of ABCB11 [21]

  Chelerythrine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chelerythrine inhibits the activity of ABCB11 [26]

  Taurolithocholate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Taurolithocholate inhibits the activity of ABCB11 [26]

  Baohuoside I

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Baohuoside I inhibits the expression of ABCB11 [60]

Patented Pharmaceutical Agent

  GW-4064

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 GW-4064 increases the expression of ABCB11 [43]

Regulation Mechanism

 via enhancement of Bile acid receptor (NR1H4) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

Drug Withdrawn

  Sitaxsentan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sitaxsentan inhibits the activity of ABCB11 [25]

  Terfenadine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Terfenadine inhibits the activity of ABCB11 [26]

Natural Product

  Cyanidin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cyanidin inhibits the activity of ABCB11 (IC50 = 7.6 microM) [10]

Cell System

 Human breast adenocarcinoma cell line (MCF-7)-BSEP

  Cyanidin-3,5-diglucoside

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cyanidin-3,5-diglucoside inhibits the activity of ABCB11 (IC50 = 43 microM) [10]

Cell System

 Human breast adenocarcinoma cell line (MCF-7)-BSEP

  Delphinidin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Delphinidin inhibits the activity of ABCB11 (IC50 = 87 microM) [10]

Cell System

 Human breast adenocarcinoma cell line (MCF-7)-BSEP

  Malvidin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Malvidin inhibits the activity of ABCB11 (IC50 = 49 microM) [10]

Cell System

 Human breast adenocarcinoma cell line (MCF-7)-BSEP

  Pelargonidin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pelargonidin inhibits the activity of ABCB11 (IC50 = 76 microM) [10]

Cell System

 Human breast adenocarcinoma cell line (MCF-7)-BSEP

  Peonidin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Peonidin inhibits the activity of ABCB11 (IC50 = 30 microM) [10]

Cell System

 Human breast adenocarcinoma cell line (MCF-7)-BSEP

  Petunidin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Petunidin inhibits the activity of ABCB11 (IC50 = 193 microM) [10]

Cell System

 Human breast adenocarcinoma cell line (MCF-7)-BSEP

  Boldine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Boldine induces the activity of ABCB11 [13]

Cell System

 Model organism in vivo (rat)

  Guggulsterone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Guggulsterone inhibits the expression of ABCB11 [45]

Regulation Mechanism

 via the inhibition of Bile acid receptor (NR1H4) Transcription Factor Info

Cell System

 Human primary hepatocytes

  Epicatechin gallate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Epicatechin gallate increases the expression of ABCB11 [47]

  Gallocatechol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gallocatechol increases the expression of ABCB11 [47]

  Particulate Matter

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Particulate Matter inhibits the expression of ABCB11 [48]

  Heliotrine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Heliotrine inhibits the expression of ABCB11 [49]

  Senecionine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Senecionine inhibits the expression of ABCB11 [49]

  Tobacco Smoke Pollution

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tobacco Smoke Pollution inhibits the expression of ABCB11 [52]

  Methyleugenol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Methyleugenol inhibits the expression of ABCB11 [58]

Environmental toxicant

  Dichlorodiphenyl Dichloroethylene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dichlorodiphenyl Dichloroethylene increases the expression of ABCB11 [54]

  Polychlorinated dibenzodioxin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Polychlorinated dibenzodioxin inhibits the expression of ABCB11 [52]

Mycotoxins

  Aflatoxin B1

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aflatoxin B1 inhibits the expression of ABCB11 [46]

Acute Toxic Substance

  Morin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Morin inhibits the activity of ABCB11 [26]

  2-methyl-4-isothiazolin-3-one

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 2-methyl-4-isothiazolin-3-one increases the expression of ABCB11 [57]

Carcinogen

  Benzo(a)pyrene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzo(a)pyrene inhibits the expression of ABCB11 [58]

Health and Environmental Toxicant

  Pirinixic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pirinixic acid inhibits the activity of ABCB11 [21]

  Perfluorooctane sulfonic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Perfluorooctane sulfonic acid inhibits the expression of ABCB11 [51]

  Diethylhexyl Phthalate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Diethylhexyl Phthalate inhibits the expression of ABCB11 [56]
References
1 Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors. Drug Metab Dispos. 2009 Sep;37(9):1878-86.
2 The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology. 2002 Nov;123(5):1649-58.
3 Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44.
4 Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes. Drug Metab Dispos. 2013 Feb;41(2):296-304.
5 Hepatobiliary disposition in primary cultures of dog and monkey hepatocytes. Mol Pharm. 2006 May-Jun;3(3):266-74.
6 Estimation of transporters involved in the hepatobiliary transport of TA-0201CA using sandwich-cultured rat hepatocytes from normal and multidrug resistance-associated protein 2-deficient rats. Drug Metab Dispos. 2010 Sep;38(9):1505-13.
7 Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology. 2000 Feb;118(2):422-30.
8 Differential modulation of farnesoid X receptor signaling pathway by the thiazolidinediones. J Pharmacol Exp Ther. 2009 Jul;330(1):125-34.
9 Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin. J Pharmacol Exp Ther. 2005 Aug;314(2):876-82.
10 Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1. Br J Pharmacol. 2009 Dec;158(8):1942-50.
11 More relevant prediction for in vivo drug interaction of candesartan cilexetil on hepatic bile acid transporter BSEP using sandwich-cultured hepatocytes. Drug Metab Pharmacokinet. 2014;29(1):94-6.
12 Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem. 2001 Oct 19;276(42):39411-8.
13 Boldine enhances bile production in rats via osmotic and farnesoid X receptor dependent mechanisms. Toxicol Appl Pharmacol. 2015 May 15;285(1):12-22.
14 Establishing Transcriptional Signatures to Differentiate PXR-, CAR-, and AhR-Mediated Regulation of Drug Metabolism and Transport Genes in Cryopreserved Human Hepatocytes. J Pharmacol Exp Ther. 2018 May;365(2):262-271.; 2018 May;365(2):262-271.
15 Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. J Hepatol. 2003 Oct;39(4):480-8.
16 Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits. J Biol Chem. 2002 Dec 27;277(52):50491-6.; 2002 Dec 27;277(52):50491-6.
17 miR-199a-5p inhibits the expression of ABCB11 in obstructive cholestasis. J Biol Chem. 2021 Dec;297(6):101400.; 2021 Dec;297(6):101400.
18 Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4. J Lipid Res. 2004 Oct;45(10):1813-25.
19 Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos. 2006 Oct;34(10):1756-63.
20 Blood cell oxidative stress precedes hemolysis in whole blood-liver slice co-cultures of rat, dog, and human tissues. Toxicol Appl Pharmacol. 2010 May 1;244(3):354-65.
21 Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci. 2010 Dec;118(2):485-500.
22 The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices. Toxicol In Vitro. 2011 Feb;25(1):80-90.
23 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
24 In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs. Chem Res Toxicol. 2012 Aug 20;25(8):1616-32.
25 A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicol Sci. 2013 Nov;136(1):216-41.
26 Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11). Toxicol Sci. 2013 Dec;136(2):328-43.
27 Inhibition of Human Hepatic Bile Acid Transporters by Tolvaptan and Metabolites: Contributing Factors to Drug-Induced Liver Injury?. Toxicol Sci. 2016 Jan;149(1):237-50.
28 UDCA and CDCA alleviate 17alpha-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats. Toxicol Appl Pharmacol. 2016 Nov 15;311:12-25.
29 Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals. Chem Res Toxicol. 2017 May 15;30(5):1219-1229.
30 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
31 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423.
32 Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways. Food Chem Toxicol. 2021 Dec;158:112664.
33 KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG02882)
34 Cloning of the dog bile salt export pump (BSEP; ABCB11) and functional comparison with the human and rat proteins. Biopharm Drug Dispos. 2008 Nov;29(8):441-8.
35 Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2. Biopharm Drug Dispos. 2007 Jan;28(1):13-8.
36 Regulation of hepatic bile acid transporters Ntcp and Bsep expression. Biochem Pharmacol. 2007 Dec 3;74(11):1665-76.
37 Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor. J Pharmacol Exp Ther. 2006 Apr;317(1):317-25.
38 Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans. Drug Metab Pharmacokinet. 2003;18(1):16-22.
39 Beneficial effects of colchicine on 17alpha-ethynylestradiol-induced cholestasis in rats. Arzneimittelforschung. 2011;61(3):173-9.
40 Characterization of the mouse bile salt export pump overexpressed in the baculovirus system. Hepatology. 2001 May;33(5):1223-31.
41 Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP. Antimicrob Agents Chemother. 2016 May 23;60(6):3372-9.
42 Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters. Drug Metab Dispos. 2016 Mar;44(3):453-9.
43 Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem. 2002 Aug 30;277(35):31441-7.; 2002 Aug 30;277(35):31441-7.
44 Nuclear factor erythroid 2-related factor 2 is a positive regulator of human bile salt export pump expression. Hepatology. 2009 Nov;50(5):1588-96.
45 The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism. J Pharmacol Exp Ther. 2007 Mar;320(3):1153-62.; 2007 Mar;320(3):1153-62.
46 Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):176-87.
47 A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):268-74.
48 Regulation of human hepatic drug transporter activity and expression by diesel exhaust particle extract. PLoS One. 2015 Mar 24;10(3):e0121232.
49 Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids: A whole genome transcriptome analysis. Toxicol In Vitro. 2015 Oct;29(7):1669-82.
50 Impact of Environmental Chemicals on the Transcriptome of Primary Human Hepatocytes: Potential for Health Effects. J Biochem Mol Toxicol. 2016 Aug;30(8):375-95.
51 The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction. Toxicol Appl Pharmacol. 2016 Aug 1;304:18-29.
52 Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate. Toxicology. 2016 Jul 1;363-364:58-71.
53 Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury. Toxicol Sci. 2018 Jun 1;163(2):374-384.
54 Organochloride pesticides modulated gut microbiota and influenced bile acid metabolism in mice. Environ Pollut. 2017 Jul;226:268-276.
55 Cellular and Molecular Effects of Prolonged Low-Level Sodium Arsenite Exposure on Human Hepatic HepaRG Cells. Toxicol Sci. 2018 Apr 1;162(2):676-687.
56 Di-(2-ethylhexyl)-phthalate induces apoptosis via the PPAR Gamma/PTEN/AKT pathway in differentiated human embryonic stem cells. Food Chem Toxicol. 2019 Sep;131:110552.
57 Methylisothiazolinone induces apoptotic cell death via matrix metalloproteinase activation in human bronchial epithelial cells. Toxicol In Vitro. 2020 Feb;62:104661.
58 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297.
59 Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression. Chem Biol Interact. 2022 Apr 1;356:109847.
60 Baohuoside I inhibits FXR signaling pathway to interfere with bile acid homeostasis via targeting ER alpha degradation. Cell Biol Toxicol. 2022 Jul 8.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.